This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
Cisplatin-Teva, 0.5 mg/ml, concentrate for solution for infusion — Description, Dosage, Side Effects | PillsCard
OTC
Cisplatin-Teva, 0.5 mg/ml, concentrate for solution for infusion
Data updated: 2026-04-11
Available in:
🇨🇿🇩🇪🇬🇧🇯🇵🇷🇴🇹🇷
Form
—
Dosage
—
Route
—
Storage
—
About This Product
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
Manufacturer
Teva Pharma AG (CH)
ATC Code
L01XA01
Source
SWISSMEDIC
(
ARTG
)
Cisplatin Injection is indicated for the palliative treatment of metastatic non-seminomatous germ cell carcinoma, advanced-stage refractory ovarian carcinoma, advanced-stage refractory bladder carcinoma and refractory squamous cell carcinoma of the head and neck. It may be used as a single agent or in combination with other chemotherapeutic agents. It may be employed, in appropriate circumstances, in addition to other modalities, eg radiotherapy or surgery.
PillsCard reference image